We identified nine Verona integron-encoded metallo-β-lactamase-2 (VIM-2)-producing Acinetobacter nosocomialis (n = 8) and Acinetobacter seifertii (n = 1) isolates from South Korea and performed whole-plasmid sequencing for two A. nosocomialis isolates and one A. seifertii isolate. Genotyping, antibiotic resistance profiles, and whole plasmid sequences indicated clonal dissemination of the eight VIM-2–producing A. nosocomialis isolates. The plasmid-bearing blaVIM-2 in the A. seifertii isolate differed from those in the A. nosocomialis isolates.
Get full access to this article
View all access options for this article.
References
1.
PoirelL., NaasT., NicolasD., ColletL., BellaisS., CavalloJ., and NordmannP.. 2000. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44:891–897.
2.
YumJ.H., YiK., LeeH., YongD., LeeK., KimJ.M, RossoliniG.M, and ChongY.. 2002. Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837–840.
3.
SungJ.Y., KooS.H, KimS., and KwonK.C.. 2014. Epidemiological characterizations of class 1 integrons from multidrug-resistant Acinetobacter isolates in Daejeon, Korea. Ann. Lab. Med. 34:293–299.
4.
KoK.S., SuhJ.Y, KwonK.T, JungS.I, ParkK.H, KangC.I, ChungD.R, PeckK.R, and SongJ.H.. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60:1163–1167.
5.
Clinical and Laboratory Standards Institute (CLSI). 2019. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-ninth Informational Supplement M100-S29. CLSI, Wayne, PA.
6.
BartualS.G., SeifertH., and HipplerC.. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382–4390.
7.
KimD.H., and KoK.S.. 2015. A distinct alleles and genetic recombination of pmrCAB operon in species of Acinetobacter baumannii complex isolates. Diagn. Microbiol. Infect. Dis. 82:183–188.
8.
KopotsaK., OseiSekyereJ., and MbelleN.M.. 2019. Plasmid evolution in carbapenemase-producing Enterobacteriaceae: a review. Ann. N. Y. Acad. Sci. 1457:61–91.
9.
WisplinghoffH., PaulusT., LugenheimM., StefankD., HigginsP.G, and EdmondM.B.. 2012. Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacterpittii, and Acinetobacter nosocomialis in the United States. J. Infect. 64:282–290.
10.
ParkK.H., ShinJ.H, LeeS.Y, KimS.H, JangM.O, and KangS.J.. 2013. The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies. PLoS One, 8:e65026.
11.
NemecA., KrizovaL., MaixnerovaM., SedoO., and BrisseS.. 2015. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolated from human clinical specimens. Int. J. Syst. Evol. Microbiol. 65:934–942.
12.
ParkY.K., JungS.I, ParkK.H, KimD.H, ChoiJ.Y, KimS.H, and KoK.S.. 2012. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years. J. Med. Microbiol. 61:71–79.
13.
KimD.H., JungS.I, KwonK.T, and KoK.S.. 2017. Occurrence of diverse AbGRI1-type genomic islands in Acinetobacter baumannii global clone 2 isolates from South Korea. Antimicrob. Agents Chemother. 61:e01972–16.
